Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
25 Cards in this Set
- Front
- Back
Nausea
|
Nausea is the subjective feeling of the need to vomit. It includes an unpleasant sensation in the mouth and stomach and can be associated with
salivation, sweating, dizziness, and tachycardia. |
|
Vomiting
|
Vomiting is the forceful expulsion of the stomach contents through the
mouth, but is preceded by the relaxation of the esophageal sphincter, contraction of the abdominal muscles, and temporary suspension of breathing. |
|
Emetic Response: Neurophysiology
|
The CNS, the peripheral nervous system, and the gastrointestinal (GI) tract
are all involved in initiating and coordinating the emetic response. In the CNS, the emetic (vomiting) center receives incoming signals from other parts of the brain and the GI tract and then coordinates the emetic response by sending signals to the effector organs. |
|
Emetic Center: Neuorphys
|
The emetic center is located in the medulla oblongata of the brain, near the
nucleus tractus solitarius (NTS). The emetic center is stimulated by neurotransmitters released from the chemoreceptor trigger zone (CTZ), the GI tract, the cerebral cortex, the limbic system, and the vestibular system. |
|
Emetic Response: Neurotransmitters
|
The major neurotransmitter receptors associated with the emetic response include serotonin (5-HT3) receptors, substance P neurokinin (NK)1 receptors, and dopamine D2 receptors. Other receptors involved include corticosteroid, acetylcholine, histamine, cannabinoid, gabaminergic, and opiate receptors.
Many of these receptors are targets for antiemetic therapy. |
|
Emetic Response: CTZ
|
Chemoreceptor trigger zone (CTZ) is located in the area postrema on the floor of the fourth
ventricle in the brainstem; it lies outside the blood–brain barrier. When the CTZ senses toxins and noxious substances in the blood and cerebrospinal fluid, it triggers the emetic response by releasing neurotransmitters that travel to the emetic center and the NTS. The major neurotransmitter receptors involved in this pathway include serotonin, dopamine, and neurokinin-1. |
|
Emetic Response: GI System
|
The GI system also plays a large part in the initiation of the emetic response. The GI tract contains enterochromaffin cells in the GI mucosa. When these cells are damaged by chemotherapy, radiation, or mechanical irritation, serotonin is released, which can stimulate the vagal afferents as well as directly stimulate the emetic center and NTS. The vomiting center then propagates the emetic response.
|
|
Emetic Response: Cerebral Ctx
|
The cerebral cortex and limbic system can stimulate the emetic center in response to emotional states such as anxiety, pain, and conditioned responses (anticipatory nausea and vomiting). Disorders of the vestibular system, such as vertigo and motion sickness, stimulate the emetic center through acetylcholine and histamine release.
|
|
Causes of nausea and vomiting (5)
|
1. Central nervous system (CNS) causes include increased intracranial pressure, migraine, brain metastases, vestibular dysfunction, alcohol intoxication, and anxiety.
2. Infectious disease causes include viral gastroenteritis, food poisoning, peritonitis, meningitis, and urinary tract infections. 3. Metabolic causes include hypercalcemia, uremia, hyperglycemia, and hyponatremia. 4. Gastrointestinal disorders, such as gastroparesis, bowel obstruction, distention, and mechanical irritation, can cause nausea and vomiting. 5. Among the many medications that can cause nausea and vomiting are cancer chemotherapy, antibiotics, antifungals, and opiate analgesics. |
|
5-HT3 receptor antagonists
1. Mechanism of action |
Granisetron and ondansetron competitively block 5-HT3 receptors located on the NTS, CTZ, and visceral afferent nerves. Thus, these drugs can prevent both peripheral and central stimulation of the vomiting center.
|
|
5-HT3 receptor antagonists---Administration and elimination
|
Granisetron and ondansetron
Oral and IV administration are equally effective; the drugs are metabolized in the liver |
|
5-HT3 receptor antagonists---Adverse Effects
|
Headache, constipation
|
|
Substance P/NK1 Antagonist
1. Mechanism of action |
Aprepitant is a competitive antagonist of substance P at NK1 receptors located in the CTZ and NTS.
|
|
Substance P/NK1 Antagonist--admin and elim
|
Aprepitant
Oral; metabolized in the liver |
|
Substance P/NK1 Antagonist---Adverse Effects
|
Aprepitant
Fatigue, hiccups, headache, and diarrhea |
|
Substance P/NK1 Antagonist--Drug interactions
|
Aprepitant
a. Corticosteroids Aprepitant decreases the clearance of dexamethasone such that the dexamethasone dose (when used as an antiemetic) should be reduced. b. Warfarin Warfarin metabolism is induced such that its clearance is increased. The dose may need to be adjusted based on the patient’s coagulation status (INR). c. Anticancer drugs Several chemotherapy agents (e.g., etoposide, ifosfamide, vinca alkaloids, and others) are metabolized by the CYP3A4 enzyme system and the metabolism of these agents may be altered by aprepitant. |
|
Corticosteroids
1. Mechanism of action |
Dexamethasone
The mechanism of action of corticosteroids as antiemetics has not been determined. Corticosteroids may decrease serotonin release, antagonize serotonin receptors, or activate corticosteroid receptors in the NTS. |
|
Corticosteroids--admin and elim
|
Dexamethasone is available in both IV and oral formulations; metabolized in the liver
|
|
Corticosteroids--Adverse Effects
|
Dexamethasone
a. Insomnia, jitteriness, increased appetite, and GI distress. b. Hyperglycemia can occur, especially in patients with pre-existing diabetes. These patients should monitor their glucose levels. |
|
Metoclopramide
|
Metoclopramide provides antiemetic effects by blocking the dopaminergic receptors centrally in the CTZ. Peripherally, metoclopramide increases lower esophageal sphincter tone, aids gastric emptying, and accelerates transit through the small bowel, possibly through the release of acetylcholine. Side
effects include sedation and extrapyramidal side effects, such as dystonia and akathesia. |
|
Prochlorperazine
|
Phenothiazines such as prochlorperazine block dopamine receptors in the CTZ. As with metoclopramide, side effects include sedation and extrapyramidal side effects.
|
|
Nabilone
|
Cannabinoids have long been used for refractory nausea and vomiting. This is based on the effect of the CNS cannabinoid receptors on the CTZ, the NTS, and the emetic center. Nabilone, an oral cannabinoid, is associated with side effects, such as drowsiness, dry mouth, dysphoria, vertigo, and euphoria.
|
|
Olanzapine
|
Olanzapine is an atypical antipsychotic agent that antagonizes several serotonin and dopamine receptors as well as other neurotransmitter receptors. The common side effects of olanzapine include sleepiness, dry
mouth, and dizziness. |
|
Scopolamine
|
Motion sickness may be associated with nausea and vomiting. Anticholinergic agents and antihistamines that cross,the blood–brain barrier effectively prevent and treat motion sickness. Scopolamine is a muscarinic,receptor antagonist that can prevent motion sickness. It is available as a topical patch, which bypasses the problem of GI symptoms associated with motion sickness.
|
|
Summary of use of antiemetics in treating nausea and vomiting
|
|